key: cord-0788974-qgag5fow
authors: Kıymet, Elif; Böncüoğlu, Elif; Şahinkaya, Şahika; Cem, Ela; Çelebi, Miray Yılmaz; Düzgöl, Mine; Kara, Aybüke Akaslan; Arıkan, Kamile Ötiken; Aydın, Tuğçe; İşgüder, Rana; Yılmazer, Murat Muhtar; Ayhan, Yüce; Gülfidan, Gamze; Bayram, Arzu; Bayram, Nuri; Çelik, Tanju; Alp, Yaşar Tamer; Devrim, İlker
title: Distribution of spreading viruses during COVID-19 pandemic: Effect of mitigation strategies
date: 2021-06-09
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2021.06.002
sha: b2bc3ad5e5bb4120973552377360ae4751357ce4
doc_id: 788974
cord_uid: qgag5fow

BACKGROUND: The study aimed to evaluate the distribution of circulating respiratory viral pathogens other than SARS-CoV-2 during the first year of the coronavirus disease–2019 (COVID-19) pandemic with especially focusing on the effects of the national-based mitigation strategies. METHODS: This single-center study was conducted between March 11, 2020-March 11, 2021. All children who were tested by polymerase chain reaction (PCR) on nasopharyngeal swabs for SARS-CoV-2 and other common respiratory viral pathogens were included in the study. RESULTS: A total of 995 children with suspected COVID-19 admitted to the study center. Of these, 513 patients who were tested by PCR for both SARS-CoV-2 and common respiratory viral pathogens were included in the final analysis. Two hundred ninety-five patients were (57.5%) male. The median age was 3 years of age (27 days-17 years). A total of 321 viral pathogens identified in 310 (n:310/513, 60.4%) patients, and 11 of them (n:11/310, 3.5%) had co-detection with more than one virus. The most common detected virus was rhinovirus (n:156/513, 30.4%), and SARS-CoV-2 (n:122/513, 23.8%) followed by RSV (n:18/513, 3.5%). The influenza virus was detected in two patients (0.4%). A total of 193 patients were negative for both SARS-CoV-2 and other pathogens. CONCLUSION: There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic.

Prof. Dr. Devrim conceptualized and designed the study, carried out the initial analyses, and reviewed and revised the manuscript.

Dr. Kıymet collected data, carried out the initial analyses, and drafted the initial manuscript.

Assoc. Prof. Bayram conceptualized and designed the study, coordinated, supervised data collection and and reviewed and revised the manuscript.

Dr. Böncüoğlu Çelik, Dr. Alp Alp designed the data collection instruments, collected data, and contributed essential intellectual content.

All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

The study aimed to evaluate the distribution of circulating respiratory viral pathogens other than SARS-CoV-2 during the first year of the coronavirus disease-2019 (COVID-19) pandemic with especially focusing on the effects of the national-based mitigation strategies.

This single-center study was conducted between March 11, 2020 -March 11, 2021 . All children who were tested by polymerase chain reaction (PCR) on nasopharyngeal swabs for SARS-CoV-2 and other common respiratory viral pathogens were included in the study.

A total of 995 children with suspected COVID-19 admitted to the study center. Of these, 513 patients who were tested by PCR for both SARS-CoV-2 and common respiratory viral pathogens were included in the final analysis. Two hundred ninety-five patients were (57.5%) male. The median age was 3 years of age (27 days-17 years). A total of 321 viral pathogens identified in 310 (n:310/513, 60.4%) patients, and 11 of them (n:11/310, 3.5%) had co-detection with more than one virus. The most common detected virus was rhinovirus (n:156/513, 30.4%), and SARS-CoV-2 (n:122/513, 23.8%) followed by RSV (n:18/513, 3.5%). The influenza virus was detected in two patients (0.4%). A total of 193 patients were negative for both SARS-CoV-2 and other pathogens.

There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic.

Keywords: co-detection; coronavirus disease-2019 (COVID-19); mitigation strategies; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

 In this study, co-detection with other viral respiratory pathogens in children with SARS-CoV-2 infections was found to be 8.2%.

 In children with suspected COVID-19 during the pandemic period, the most common detected viral respiratory pathogens were rhinovirus (30.4%), SARS-CoV-2 (23.8%) followed by RSV (3.5%) and enteroviruses (1.7%).

 Remarkably, influenza virus detected only in two children which were found to be in the initial period of pandemic.

 There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic.

Since the beginning of the coronavirus disease-2019 (COVID-19) (1), it has become one of the worst infectious disease pandemics of recent times (2). Up to March 2021, more than 115 million confirmed cases of COVID-19 with 2.560.287 deaths were reported worldwide (3).

Before the COVID-19 pandemic, respiratory pathogens such as influenza, parainfluenza, respiratory syncytial virus (RSV), human metapneumovirus (hMPV) and human coronavirus (HCoV) are reported to be responsible for the respiratory tract infections in children (4) (5) (6) . For now, it has also been reported of co-infections of SARS-CoV-2 and other respiratory pathogens (7) (8) (9) (10) (11) . There are some studies that revealed a general reduction in the prevalence of other seasonal respiratory viruses that are attributed to the preventive measures for COVID-19 (12) (13) (14) . Moreover, the impact of the national based mitigation strategies including lockdowns, suspension of the schools, mandatory facial mask usage also which would change the viral pathogens circulating during the pandemic is not obvious.

This descriptive study aimed to evaluate the distribution of respiratory viral pathogens other than the SARS-CoV-2 during the first year of the COVID-19 pandemic with especially focusing on the effects of the national based mitigation strategies on the circulating respiratory viral pathogens.

This single-center cross-sectional study was conducted in the University of Health Sciences Dr Behçet Uz Children's Hospital with a 360-bed tertiary care hospital in İzmir, Turkey, from March 11, 2020, to March 11, 2021 . This hospital is a pediatric referral center in the Aegean Region of Turkey with annual approximately 600,000 outpatients and 24,000 hospitalizations.

All children (≤18 years old) who were tested by polymerase chain reaction (PCR) on nasopharyngeal swabs for SARS-CoV-2 and other common human respiratory tract pathogens were included in the study. Demographic and microbiological data of the patients were obtained from hospital medical records. Statistical analysis was performed using SPSS statistical software (version 22; SPSS, Chicago, IL, USA). Measurement data with normal distribution are expressed as mean ± standard deviation (mean ± SD).

In Turkey, the first case of COVID-19 was announced on March 11, 2020 (17) . As a result of pandemic, some preventive measures were implemented by Ministry of Health. Firstly, face to face educations in primary, secondary and high schools were suspended since March 16, 2020 (18). On April 3, 2020, children were restricted from leaving their houses which achieved to reduce their contact with each other and with society. In addition to the lockdown, mandatory face mask usage in public areas is a general rule among the country, since April 3, 2020 (19) . On October 12, 2020, face-to-face education was started in all primary schools, Children were allowed to leave their house on particular days of the week and particular hours of the day for less than 4 hours during the curfews.

This study was approved by the Local Ethical Committee of University of Health Science Dr.

Behcet Uz Children's Training and Research Hospital.

During the study period, a total of 995 children with suspected COVID-19 admitted to the study center. Of these, 513 patients who were tested by PCR for both SARS-CoV-2 and other common respiratory viral pathogens were included in the final analysis. Two hundred ninetyfive patients were (57.5%) male and 218 patients (42.5%) were female. The median age was 3 years of age (ranging from 27 days of life to 17 years of age). One hundred sixty-nine patients (32.9%) of the patients were younger than 1 year of age, 132 patients (68.0%) were under 6 years of age, and 98 patients (18.1%) were older than 12 years of age.

Of 513 patients, 122 (23.8%) were positive for SARS-CoV-2. The mean age of these patients with COVID-19 was 7.2 ± 5.8 years (ranging from 27 days to 17 years) and the mean age of patients with negative SARS-CoV-2 was 4.5 ± 4.8 years (ranging from 28 days to 17.5 years).

The difference of the patients' ages was significantly higher in children with COVID-19 (p<0.05).

A total of 321 viral pathogens including respiratory viral pathogen and/or SARS-CoV-2 were identified in 310 (n: 310/513, 60.4%) patients and of them 11 (n:11/310, 3.5%) had co- 9 9 detection with more than one virus. A total of 193 (37.6%) patients were negative for both SARS-CoV-2 and the other viral pathogens.

During the study period, the most common detected viral pathogen was rhinovirus 

In this study, co-detection with other viral respiratory pathogens in children with SARS-CoV-2 infections was found to be 8.2%. In children with suspected COVID-19 during the pandemic period, the most common detected viral respiratory pathogens were rhinovirus (30.4%), SARS-CoV-2 (23.8%) followed by RSV (3.5%) and enteroviruses (1.7%).

Remarkably, influenza virus detected only in two children which were found to be in the initial period of pandemic. There is a decline in the frequency of all viral pathogens like SARS-CoV-2 in correlation with the national-based mitigation strategies against COVID-19 during the pandemic.

The studies focusing on viral co-infections with SARS-CoV-2 are mostly in adults. Some studies generally show the rates of co-infection as 3.2% -4.3% (21, 22) . In another study, of 21 patients infected with SARS-CoV-2, two samples were also positive for influenza A (9.5%) and one positive for PIV-3 (4.76%) (23) . Qin Wu et al. reported that a total of 19 patients (51.35%) among the 34 pediatric patients with COVID-19 were also positive for other common respiratory pathogens (9) . In another study from China, which included 20 pediatric patients, found the rate of coinfection to be 40% (24) . In the current study, codetection with other viral pathogens and SARS-CoV-2 in children was found to be as 8.2%

and rhinovirus was the most common co-detected virus. According to a review that evaluated several aspects of co-infection in COVID-19 comprehensively, overall the co-infection frequency with other viral pathogens was detected low, and rhinovirus/enterovirus, respiratory syncytial virus, and influenza viruses were more detected common co-virus pathogens (11) .

Interestingly, the current study showed influenza virus positivity in only two patients (0.4%) during the study period. This result is extremely low that influenza viruses are one of the most detected pathogens in patients with respiratory infections. As an example, according to the previous study which was conducted at the same center before the pandemic, 131 patients were hospitalized for influenza-related lower respiratory tract infections between January 2016 and March 2018 (25) . This decrease in influenza rate is thought to be related to the infection control measures performed to reduce the spreading of SARS-CoV-2. Data from the countries in Southern Hemisphere indicated also decreased influenza activity mostly due to the widespread mitigation measures (26). In our country, influenza vaccination is not mandatory and influenza vaccine shortage was present due to the high demand during the pandemic. Thus, the low influenza detection rate in our country might be as a result of the suspending of the schools throughout the COVID-19 pandemic at the winter period.

In this study, RSV was detected in 3.5% of the patients that was similar to recent studies which showed the detection rates of RSV approximately 3-9% (10, 27, 28) . Moreover, some studies also pointed out a decline in the incidence of RSV detection similar to our findings (13, 14) . According to a study which aimed to describe the effects of the nationwide lockdown strategy on the incidence of influenza A, influenza B, and RSV infections among children in Finland, influenza and RSV seasons ended more rapidly compared with previous seasons among the pediatric population in 2020 (13) . Yeoh et al. revealed that incidence of RSV and influenza declined as 98% and 99.4% respectively after the initiation of local COVID-19 restrictions compared with data of pre-pandemic years (14) .

Studies have reported the declined rates of infectious diseases during the pandemic such as influenza, chickenpox, herpes zoster, rubella, or measles which have transmission route of droplet and/or airborne (29) (30) (31) . However, according to the literature, rhinovirus-related respiratory tract infection outbreaks continue to be seen especially in children (32) . In this study, it was detected that rhinovirus is the most common pathogen during the pandemic as shown in figure 1 . While there is a decline in rates of other viral pathogens during the pandemics, the spread of the rhinovirus seems to be as unaffected and so it is still the most frequently detected pathogen during the study year. Leung et al identified that the viruses in coughs and exhaled breath of children and adults with acute respiratory illness by seasonal human coronaviruses, influenza viruses, and rhinoviruses (33) . According to this study, surgical face masks significantly reduced the detection of influenza virus RNA in respiratory droplets and coronavirus RNA in aerosols, but for rhinovirus, there were no significant differences between detection of virus with or without surgical face masks, both in respiratory droplets and in aerosols (33) . These findings support the results of our study.

After a short time after the first announcement of the first COVID-19 case in Turkey, the schools including day care centers, primary and high schools were suspended, and later the daily care centers were also suspended. In addition, facial mask was set to be mandatory even in the social daily lifetime. These measures reduced the frequency of all viral respiratory pathogens as well as SARS-CoV-2. The correlation between the number of cases and the rigidity of limitation strategies is seen in figure-1. Thus the viral pathogens which are expected be more contagious in the crowded placed were not observed during COVID-19

pandemic.

There are several limitations of this study due to its retrospective design and including only a single pediatric center. Moreover, data of this study includes only hospitalized pediatric patients and the findings may not be attributed to the whole population. However, we must emphasize that the present study includes one of the largest pediatric population which may

give an opinion about the distribution in population. From the beginning of the COVID-19 pandemic, most of the hospitals preferred only performing PCR tests for SARS-CoV-2, instead of other viral pathogens due to more efficient use of resources and laboratories and safety precautions. Thus this study provides the first and initial sight of view about the distribution of other viral respiratory pathogens during the SARS-CoV-2 outbreak in pediatric patients in Turkey.

In conclusion, rates and distribution of detected concomitant viral respiratory tract pathogens with SARS-CoV-2 are similar with adults and are not as much higher than early reports during the initial period of pandemic. In addition, the circulating viruses during the COVID-19 pandemic can change due to multifactorial factors including season, geographical variance 13 13 and also the national mitigation strategies in which changed the distribution of the viruses them we expected or observed in the previous year.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

World Health Organization): Coronavirus disease (COVID-2019) situation reports

Viral pathogens associated with acute lower respiratory tract infections in children younger than 5 years of age in Bulgaria

Etiology of coinfections in children with influenza during 2015/16 winter season in Nepal

Complicating Infections Associated with Common Endemic Human Respiratory Coronaviruses. Health Secur

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children

Co-infection and Other Clinical Characteristics of COVID-19 in Children

Characterizing coinfection in children with COVID-19: a dual center retrospective analysis

The Complexity of Co-Infections in the Era of COVID-19

Where have all the viruses gone? Disappearance of sea-sonal respiratory viruses during the COVID-19 pandemic

Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020

The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter

Turkey confirms first case of coronavirus

Türkiye'nin koronavirüsle mücadelesinde son 24 saatte yaşananlar

Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients

The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan

Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

Influenza-related hospitalizations due to acute lower respiratory tract infections in a tertiary care children's hospital in Turkey

Decreased Influenza Activity During the COVID-19 Pandemic -United States

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes

Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan

Positive effects of COVID-19 control measures on influenza prevention

The impact of COVID-19 control measures on the morbidity of varicella, herpes zoster, rubella and measles in Guangzhou

Rhinovirus remains prevalent in school teenagers during fight against COVID-19 pandemic

Respiratory virus shedding in exhaled breath and efficacy of face masks